Literature DB >> 2030368

The proliferation rate of T and B lymphocytes in cerebrospinal fluid.

R S Thomas1, W Beuche, K Felgenhauer.   

Abstract

An immunocytochemical method is presented by which individual proliferating T and B lymphocytes can be detected in the cerebrospinal fluid (CSF) of patients with inflammatory and neoplastic diseases of the central nervous system. The absolute numbers of proliferating T and B lymphocytes were approximately equal, so that only a minority of the strongly prevailing T-cell population proliferates in the CSF during the immune process. The highest proliferation (25.7%) was found within the small subset of activated, i.e. cytoplasmic immunoglobulin-containing, B lymphocytes. This provides further evidence that these cells are not the terminally differentiated plasma cells of classical cytology but progenitor cells capable of further proliferation. B-cell lymphomas could be easily identified. The detection of abnormally proliferating cell subsets could help in the differentiation of opportunistic infection from leukaemic infiltration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2030368     DOI: 10.1007/bf00319706

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  Immunocytochemical identification of meningeal leukemia and lymphoma: poly-L-lysine-coated slides permit multimarker analysis even with minute cerebrospinal fluid cell specimens.

Authors:  B R Kranz; E Thiel; S Thierfelder
Journal:  Blood       Date:  1989-05-15       Impact factor: 22.113

2.  Cerebrospinal fluid lymphocytes from patients with multiple sclerosis do not increase immunoglobulin or measles antibody production after stimulation with pokeweed mitogen.

Authors:  A Henriksson; S Kam-Hansen; P Forsberg; M Grandien
Journal:  J Neuroimmunol       Date:  1986-03       Impact factor: 3.478

3.  Diagnostic significance of IgG-synthesizing activated B cells in acute inflammatory diseases of the central nervous system.

Authors:  H J Schädlich; K Felgenhauer
Journal:  Klin Wochenschr       Date:  1985-06-03

Review 4.  Cellular events in the differentiation of antibody-secreting cells.

Authors:  J E Calvert; S Maruyama; T F Tedder; C F Webb; M D Cooper
Journal:  Semin Hematol       Date:  1984-10       Impact factor: 3.851

Review 5.  Immunoglobulin as a differentiation and clonal marker.

Authors:  N R Ling
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

Review 6.  Immune markers in the diagnosis of malignant lymphomas.

Authors:  E S Jaffe
Journal:  J Virol Methods       Date:  1988-09       Impact factor: 2.014

7.  Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.

Authors:  K Sheibani; C D Winberg; S van de Velde; D W Blayney; H Rappaport
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

8.  Immunohistochemical identification of proliferating cells in organ culture using bromodeoxyuridine and a monoclonal antibody.

Authors:  G Morstyn; K Pyke; J Gardner; R Ashcroft; A de Fazio; P Bhathal
Journal:  J Histochem Cytochem       Date:  1986-06       Impact factor: 2.479

9.  The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.

Authors:  A S Bellamy; V L Calder; M Feldmann; A N Davison
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

10.  Expression of Tac antigen on activated normal human B cells.

Authors:  M Tsudo; T Uchiyama; H Uchino
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  1 in total

1.  Immunological differentiation between tickborne encephalitis with and without concomitant neuroborreliosis.

Authors:  J Tomazic; A Ihan; F Strle; J Cimperman; J Stare; M Maticic; B Zakotnik
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.